Septerna SEPN
NASDAQ SEPN
$51.11 +0.37 (+0.73%)
As of: Nov 10, 2026 · 2:50 PM EST

Septerna (SEPN) EBT (2023 - 2026)

Updated

Septerna's EBT came in at -$12.06 million for Q2 2026, compared with -$24.84 million a year earlier.

Analysis

Septerna (SEPN) EBT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Septerna reported EBT of -$22.91 million; for FY2025, it was -$48.87 million.

  • Going back by year, EBT was -$72.3 million in FY2024 and -$48.87 million in FY2023.
  • The five-year range for quarterly EBT is -$24.84 million (Q2 2025) to $8.17 million (Q3 2025).
  • Business Quant data shows SEPN's EBT at -$8.3 million (Q1 2026), -$10.73 million (Q4 2025) and $8.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 34.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 4.83 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 2.80 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.06 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.39 Bn
10 Septerna 2.27 Bn 687.56 Mn - -12.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.06 Mn
Mar 31, 2026 -8.30 Mn
Dec 31, 2025 -10.73 Mn
Sep 30, 2025 8.17 Mn
Jun 30, 2025 -24.84 Mn
Mar 31, 2025 -21.48 Mn
Dec 31, 2024 -20.83 Mn
Sep 30, 2024 -20.66 Mn
Jun 30, 2024 -16.55 Mn
Mar 31, 2024 -14.26 Mn
Dec 31, 2023 -18.15 Mn
Sep 30, 2023 -10.95 Mn
API Access

Septerna EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=SEPN&period=max&api_key=YOUR_API_KEY